ArticleThe Journal of antimicrobial chemotherapy2018

Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients.

Nicholas S Britt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.